PATIENTS WITH PSORIATIC ARTHRITIS (PSA) TREATED WITH ADALIMUMAB ACHIEVED CLINICAL REMISSION AND GOOD CLINICAL RESPONSES IN THE STEREO TRIAL

被引：0
|
作者：
Reece, Richard [5 ]
Van den Bosch, Filip [1 ]
Manger, Bernhard [2 ]
Goupille, Philippe [3 ]
Kron, Martina [4 ]
Kary, Sonja [4 ]
Kupper, Hartmut [4 ]
机构：
[1] Univ Hosp, Ghent, Belgium
[2] Univ Erlangen Nurnberg, Erlangen, Germany
[3] Univ Hosp, Tours, France
[4] Abbott GmbH & Co KG, Ludwigshafen, Germany
[5] Calderdale & Huddersfield NHS Fdn Trust, Leeds, W Yorkshire, England
来源：
RHEUMATOLOGY | 2009年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：I55 / I56
页数：2
相关论文
共 50 条
  • [21] Clinical Responses and Synovial Vascularity in Obese Rheumatoid Arthritis Patients Treated with Adalimumab and Methotrexate
    Kaeley, Gurjit S.
    MacCarter, Daryl K.
    Pangan, Aileen L.
    Wang, Xin
    Kalabic, Jasmina
    Ranganath, Veena K.
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (12) : 1628 - 1635
  • [22] SEVERITY OF BASELINE SKIN DISEASE DOES NOT CORRELATE WITH CLINICAL, PATIENT-REPORTED OR RADIOGRAPHIC RESPONSES IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH ADALIMUMAB
    Landewe, Robert
    Dianne Nguyen
    Heckaman, Michele
    Mease, Philip
    RHEUMATOLOGY, 2012, 51 : 88 - 88
  • [23] PRESENCE OF ANTIBODIES TO ADALIMUMAB AND INFLIXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN CLINICAL REMISSION
    Eng, G.
    Fana, V.
    Omerovic, E.
    Hojsgaard, P.
    Lindegaard, H. M.
    Jensen, E. K.
    Bouchelouche, P. N.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 230 - 230
  • [24] TIME TO RESPONSE FOR CLINICAL AND PATIENT-REPORTED OUTCOMES IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH TOFACITINIB, ADALIMUMAB OR PLACEBO
    Gladman, D. D.
    Coates, L. C.
    Wu, J.
    Fallon, L.
    Hsu, M. A.
    Bushmakin, A. G.
    Bacci, E.
    Cappelleri, J. C.
    Helliwell, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1681 - 1681
  • [25] Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo
    Gladman, Dafna D.
    Coates, Laura C.
    Wu, Joseph
    Fallon, Lara
    Bacci, Elizabeth D.
    Cappelleri, Joseph C.
    Bushmakin, Andrew G.
    Helliwell, Philip S.
    ARTHRITIS RESEARCH & THERAPY, 2022, 24 (01)
  • [26] Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo
    Dafna D. Gladman
    Laura C. Coates
    Joseph Wu
    Lara Fallon
    Elizabeth D. Bacci
    Joseph C. Cappelleri
    Andrew G. Bushmakin
    Philip S. Helliwell
    Arthritis Research & Therapy, 24
  • [27] Time to Response for Clinical and Patient-Reported Outcomes in Patients with Psoriatic Arthritis Treated with Tofacitinib, Adalimumab, or Placebo
    Gladman, Dafna
    Coates, Laura
    Wu, Joseph
    Fallon, Lara
    Hsu, Ming-Ann
    Bushmakin, Andrew
    Bacci, Elizabeth
    Cappelleri, Joseph
    Helliwell, Philip
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [28] PSORIATIC-ARTHRITIS (PSA) - CLINICAL, GENETIC AND THERAPEUTIC CONSIDERATIONS IN 100 PATIENTS
    SCHUR, PH
    KAMMER, GM
    SOTER, NA
    CLINICAL RESEARCH, 1979, 27 (02): : A475 - A475
  • [29] Durable Clinical Remission and Response in Adalimumab-Treated Patients with Ulcerative Colitis
    Panaccione, R.
    Colombel, J. -F.
    Sandborn, W. J.
    Reinisch, W.
    D'Haens, G.
    Hommes, D.
    Ghosh, S.
    Pappalardo, B.
    Petersson, J.
    Robinson, A. M.
    Lazar, A.
    Zhou, Q.
    Thakkar, R. B.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S256 - S257
  • [30] Durable Clinical Remission and Response in Adalimumab-Treated Patients With Ulcerative Colitis
    Panaccione, Remo
    Colombel, Jean-Frederic
    Sandborn, William
    Reinisch, Walter
    D'Haens, Geert R.
    Hommes, Daniel W.
    Ghosh, Subrata
    Pappalardo, Brandee
    Petersson, Joel
    Robinson, Anne M.
    Lazar, Andreas
    Zhou, Qian
    Thakkar, Roopal
    GASTROENTEROLOGY, 2015, 148 (04) : S264 - S264
12345